UK markets closed

Cara Therapeutics, Inc. (CARA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
11.94-0.67 (-5.31%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close12.61
Open12.57
Bid11.70 x 800
Ask12.05 x 800
Day's range11.89 - 12.57
52-week range11.80 - 29.65
Volume669,758
Avg. volume862,080
Market cap597.621M
Beta (5Y monthly)1.10
PE ratio (TTM)41.17
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Could The Cara Therapeutics, Inc. (NASDAQ:CARA) Ownership Structure Tell Us Something Useful?
    Simply Wall St.

    Could The Cara Therapeutics, Inc. (NASDAQ:CARA) Ownership Structure Tell Us Something Useful?

    A look at the shareholders of Cara Therapeutics, Inc. ( NASDAQ:CARA ) can tell us which group is most powerful...

  • Is Cara Therapeutics a Buy for Summer 2021?
    Motley Fool

    Is Cara Therapeutics a Buy for Summer 2021?

    The future of this troubled clinical-stage biotech rests on a single drug candidate that management hopes will treat an extremely common condition.

  • Is Cara Therapeutics a Buy?
    Motley Fool

    Is Cara Therapeutics a Buy?

    With the clinical trial process in the rearview mirror, a lot of the risks associated with development are in the past, leaving "only" the risks of competing profitably. Such is the situation of Cara Therapeutics (NASDAQ: CARA), which is developing a drug called Korsuva to treat pruritus. You've probably experienced pruritus (at least to a small degree) before, because it's the sensation of itchiness.